HealthCare Global Enterprises (NSE:HCG) Piotroski F-Score: 5 (As of Jun. 27, 2026) — Near Median


NSE:HCG HealthCare Global Enterprises Ltd NSE:HCG
79 GF Score
Price ₹600.40
GF Value ₹576.14
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is HealthCare Global Enterprises Piotroski F-Score?

HealthCare Global Enterprises NSE:HCG -2.25% 79 Piotroski F-Score is 5 as of Jun. 27, 2026, which is at its 10-year median of 5.00. GuruFocus rates NSE:HCG with a GF Score™ of 79/100 and a GF Value™ of ₹576.14 (Fairly Valued). The stock has 2 warning signs investors should review. Among 652 Healthcare Providers & Services companies, HealthCare Global Enterprises ranks better than 54.6% on this metric.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

HealthCare Global Enterprises has an F-score of 5 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for HealthCare Global Enterprises's Piotroski F-Score or its related term are showing as below:

NSE:HCG' s Piotroski F-Score Range Over the Past 10 Years
Min: 2   Med: 5   Max: 7
Current: 5

During the past 12 years, the highest Piotroski F-Score of HealthCare Global Enterprises was 7. The lowest was 2. And the median was 5.

HealthCare Global Enterprises  (NSE:HCG) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


HealthCare Global Enterprises Piotroski F-Score Related Terms


HealthCare Global Enterprises Piotroski F-Score Historical Data

* Premium members only.

The historical data trend for HealthCare Global Enterprises's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

HealthCare Global Enterprises Piotroski F-Score Chart

HealthCare Global Enterprises Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.00 6.00 5.00 5.00 5.00

HealthCare Global Enterprises Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.00 0.00 0.00 0.00 5.00

NSE:HCG vs HCA, THC, DVA: Piotroski F-Score Comparison

For the Medical Care Facilities subindustry, HealthCare Global Enterprises's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


HealthCare Global Enterprises Piotroski F-Score vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, HealthCare Global Enterprises's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where HealthCare Global Enterprises's Piotroski F-Score falls into.


NSE:HCG
79GF Score
HealthCare Global Enterprises Ltd NSE:HCG
Piotroski F-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Net Income was ₹138 Mil.
Cash Flow from Operations was ₹3,471 Mil.
Revenue was ₹25,384 Mil.
Gross Profit was ₹12,971 Mil.
Average Total Assets from the begining of this year (Mar25)
to the end of this year (Mar26) was (35432.36 + 39225.4) / 2 = ₹37328.88 Mil.
Total Assets at the begining of this year (Mar25) was ₹35,432 Mil.
Long-Term Debt & Capital Lease Obligation was ₹13,592 Mil.
Total Current Assets was ₹11,352 Mil.
Total Current Liabilities was ₹10,172 Mil.
Net Income was ₹444 Mil.

Revenue was ₹22,181 Mil.
Gross Profit was ₹11,559 Mil.
Average Total Assets from the begining of last year (Mar24)
to the end of last year (Mar25) was (27074.98 + 35432.36) / 2 = ₹31253.67 Mil.
Total Assets at the begining of last year (Mar24) was ₹27,075 Mil.
Long-Term Debt & Capital Lease Obligation was ₹13,797 Mil.
Total Current Assets was ₹8,438 Mil.
Total Current Liabilities was ₹10,464 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

HealthCare Global Enterprises's current Net Income (TTM) was 138. ==> Positive ==> Score 1.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

HealthCare Global Enterprises's current Cash Flow from Operations (TTM) was 3,471. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Mar25)
=137.6/35432.36
=0.00388346

ROA (Last Year)=Net Income/Total Assets (Mar24)
=444.1/27074.98
=0.0164026

HealthCare Global Enterprises's return on assets of this year was 0.00388346. HealthCare Global Enterprises's return on assets of last year was 0.0164026. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

HealthCare Global Enterprises's current Net Income (TTM) was 138. HealthCare Global Enterprises's current Cash Flow from Operations (TTM) was 3,471. ==> 3,471 > 138 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Mar26)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar25 to Mar26
=13591.7/37328.88
=0.36410683

Gearing (Last Year: Mar25)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar24 to Mar25
=13796.7/31253.67
=0.44144256

HealthCare Global Enterprises's gearing of this year was 0.36410683. HealthCare Global Enterprises's gearing of last year was 0.44144256. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Mar26)=Total Current Assets/Total Current Liabilities
=11352.1/10171.6
=1.11605844

Current Ratio (Last Year: Mar25)=Total Current Assets/Total Current Liabilities
=8437.97/10464.18
=0.80636705

HealthCare Global Enterprises's current ratio of this year was 1.11605844. HealthCare Global Enterprises's current ratio of last year was 0.80636705. ==> This year's current ratio is higher. ==> Score 1.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

HealthCare Global Enterprises's number of shares in issue this year was 143.333. HealthCare Global Enterprises's number of shares in issue last year was 142.34. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=12970.6/25384.3
=0.51096938

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=11558.7/22181.4
=0.52109876

HealthCare Global Enterprises's gross margin of this year was 0.51096938. HealthCare Global Enterprises's gross margin of last year was 0.52109876. ==> Last year's gross margin is higher ==> Score 0.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Mar25)
=25384.3/35432.36
=0.71641573

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Mar24)
=22181.4/27074.98
=0.81925822

HealthCare Global Enterprises's asset turnover of this year was 0.71641573. HealthCare Global Enterprises's asset turnover of last year was 0.81925822. ==> Last year's asset turnover is higher ==> Score 0.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=1+1+0+1+1+1+0+0+0
=5

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

HealthCare Global Enterprises has an F-score of 5 indicating the company's financial situation is typical for a stable company.

Frequently Asked Questions Learn more about Piotroski F-Score →
What does a Piotroski F-Score of 5 mean?
HealthCare Global Enterprises (NSE:HCG) has a Piotroski F-Score of 5 as of Jun. 27, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on HealthCare Global Enterprises and its competitors. This is near median its historical median of 5.00. Over the past decade, HealthCare Global Enterprises' Piotroski F-Score has ranged from 2.00 to 7.00. According to the industry distribution chart, HealthCare Global Enterprises ranks #296 out of 652 companies in the Healthcare Providers & Services industry, placing it in the top 45.4%.
Is HealthCare Global Enterprises' Piotroski F-Score too high?
HealthCare Global Enterprises' current Piotroski F-Score of 5 is near median its 10-year median of 5.00. Over the past 10 years, this metric has ranged from a low of 2.00 to a high of 7.00. The Healthcare Providers & Services industry median Piotroski F-Score is 5.00. HealthCare Global Enterprises' value of 5 is 0% at this industry median. Based on the distribution chart, HealthCare Global Enterprises ranks #296 out of 652 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, HealthCare Global Enterprises has a GF Score™ of 79/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does HealthCare Global Enterprises' Piotroski F-Score compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, HealthCare Global Enterprises ranks #296 out of 652 companies for Piotroski F-Score. This puts HealthCare Global Enterprises in the upper half of its industry. The industry median Piotroski F-Score is 5.00. HealthCare Global Enterprises' value of 5 is 0% at this benchmark. Historically, HealthCare Global Enterprises' own Piotroski F-Score has ranged from 2.00 to 7.00 over the past decade. While the company's 10-year median is 5.00 vs. the industry median of 5.00, HealthCare Global Enterprises has consistently been at the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Healthcare Providers & Services company?
The median Piotroski F-Score among Healthcare Providers & Services companies is 5.00, based on 652 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. HealthCare Global Enterprises's current Piotroski F-Score of 5 is 0% at the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on HealthCare Global Enterprises and its competitors. For the Healthcare Providers & Services industry, the median Piotroski F-Score is 5.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. HealthCare Global Enterprises's current Piotroski F-Score is 5, which is near median its own 10-year median of 5.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HealthCare Global Enterprises stock overvalued right now?
Based on GuruFocus' analysis, HealthCare Global Enterprises (NSE:HCG) is currently considered Fairly Valued. The stock's GF Value™ is ₹576.14, compared to a current price of ₹600.40 — trading 4.2% above its estimated fair value. The current Piotroski F-Score is 5, which is near median its 10-year median of 5.00 and 0% at the Healthcare Providers & Services industry median of 5.00. HealthCare Global Enterprises' overall GF Score™ is 79/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For HealthCare Global Enterprises (NSE:HCG), the current Piotroski F-Score is 5 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is HealthCare Global Enterprises (NSE:HCG) Overvalued in 2026?

Based on GuruFocus' analysis, HealthCare Global Enterprises stock appears to be overvalued. The current stock price of ₹600.40 is trading 4.2% above its estimated GF Value™ of ₹576.14. GuruFocus considers HealthCare Global Enterprises to be Fairly Valued.

Key valuation signals for NSE:HCG:

  • Piotroski F-Score: 5 (near median its 10-year median of 5.00)
  • GF Value™: ₹576.14 vs. price of ₹600.40 (4.2% above fair value)
  • GF Score™: 79/100 with 2 warning signs
  • Industry Position: 0% at the Healthcare Providers & Services median (#296 of 652)

No single metric tells the full story. See the NSE:HCG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


HealthCare Global Enterprises Business Description

Other Exchanges 539787:India
Address Mission Road, No. 3, Ground Floor, Tower Block, Unity Building Complex, Bengaluru, KA, IND, 560027
HealthCare Global Enterprises Ltd operates in oncology, providing comprehensive cancer diagnosis and treatment services including medical oncology, radiation therapy, and surgical oncology. It also offers fertility treatment services under the Milann brand, along with multi-specialty hospital care in key medical disciplines. The company's operations span many metropolitan and non-metro cities across India and extend internationally with cancer care centers in Africa. HCG generates revenue through patient services in oncology, fertility treatments, diagnostics, and multi-specialty hospital care, leveraging technology and a networked business model to deliver patient-centric healthcare.
79GF Score

Get the complete analysis for NSE:HCG

Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹600.40
Price
₹576.14
GF Value